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Abstract Primary immunodeficiencies (PIDs) are character-
ized by an increased susceptibility to infections due to
defects in one ore more components of the immune system.
Although most PIDs are relatively rare, they are more
frequent than generally acknowledged. Early diagnosis and
treatment of PIDs save lives, prevent morbidity, and improve
quality of life. This early diagnosis is the task of the
pediatrician who encounters the child for the first time: he/
she should suspect potential PID in time and perform the
appropriate diagnostic tests. In this educational paper, the
first in a series of five, we will describe the most common
clinical presentations of PIDs and offer guidelines for the
diagnostic process, as well as a brief overview of therapeutic
possibilities and prognosis.
Keywords Primary immunodeficiency.Diagnosis.
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Introduction
Primary immunodeficiencies (PIDs) are characterized by
defects in the development and function of the human
immune system. As a result, there is an increased suscepti-
bility to infections, although some PIDs rather present with
autoimmunity or lymphoproliferation. To date, the molecular
basis of more than 150 PIDs has been unraveled and this
number is increasing rapidly [10]. PIDs can be separated into
eight categories, depending on which part of the immune
system is dysfunctional [10]( T a b l e1). An overview of the
frequency of PID diagnoses in the database of the European
Society for Immunodeficiencies (ESID) shows that primary
antibody deficiencies constitute more than half of the
reported PID diagnoses [7] (Fig. 1). Other frequently
reported PID categories are the predominantly T-cell
disorders, abnormalities in granulocyte number or function,
and the other well-defined immunodeficiency syndromes.
The estimated prevalence differs widely per individual PID
diagnosis, from approximately 1:500 for IgA deficiency—
being the most frequent, but often asymptomatic—to
>1:100,000 for very serious forms of severe combined
immunodeficiency (SCID), immune dysregulation syndromes,
and complement deficiencies. Although most PIDs are
relatively rare, they are more frequent than generally acknowl-
edged. There is a lack of awareness of PIDs among the public
and health care workers alike, resulting in diagnostic delay.
(http://ec.europa.eu/health/ph_projects/2005/action1/docs/
action1_2005_exs_01_en.pdf). However, early diagnosis and
treatment of PIDs save lives, prevent morbidity, and improve
quality of life. In this educational paper, the first in a series of
five, we will describe the clinical presentations of PIDs and
offer guidelines for the diagnostic evaluation of suspected
PID, as well as a brief overview of therapeutic possibilities
and prognosis. The differentc a t e g o r i e so fP I D sw i l lb e
described in more detail in the remainder of the educational
reviews in future issues of the Journal. The field of PID is too
extensive to cover all different PIDs known to date. Therefore,
the subsequent reviews will focus on the four largest PID
categories: antibody deficiencies, T-cell disorders, disorders of
granulocyte number and/or function, and the category of other
well-defined immunodeficiency syndromes.
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It is not easy to timely identify potential PID patients among
t h em a n yc h i l d r e ns e e ni ne v e r y d a yp r a c t i c eb yp e d i a t r i c i a n s ;
PIDs often present with very common and/or aspecific signs
and symptoms [5]. The relative rarity of the individual PIDs
also contributes to the diagnostic challenge. As a conse-
quence, diagnostic delay is common [4,15]. An effective
diagnostic strategy should be able to quickly identify PIDs
with rapidly fatal complications like severe combined
immunodeficiency (SCID) and to limit diagnostic delay in
children with PIDs with a more protracted course like
common variable immunodeficiency disorders (CVIDs),
who may develop bronchiectasis with pulmonary disability
[15] and decreased life span if treatment is delayed.
The best way to efficiently recognize PIDs in children is
to rely on adequate “pattern recognition” of the various
clinical presentations, followed by an initial limited set of
laboratory examinations, aiming at the exclusion of a PID
with rapidly fatal complications. A diagnostic protocol
including more detailed investigations can be used when
the initial examinations are compatible with a PID or when
clinical problems persist despite a normal initial evaluation.
For this, the elaborate ESID multistep diagnostic protocol for
PIDs is very useful [5]. Eventually, the aim is to establish a
genetic diagnosis by sequence analysis of candidate genes,
which is important to guide treatment and follow-up of PID
patients, as well as genetic counseling of families [16].
However, in a substantial proportion of PID patients, genetic
defects have not been found so far.
PIDs often present with very common and/or aspecific signs and symptoms
The initial evaluation of suspected PID consists of a limited set of widely
available laboratory examinations
Clinical presentation and diagnosis of PID
Analysis of a child with potential PID begins with the
history and physical examination like in any other
situation in pediatric practice. Symptoms and signs
suggestive of PID summarized in Tables 2 and 3 can be
used as warning signs (http://www.info4pi.org/aboutPI/
pdf/General10WarningSignsFINAL.pdf). PIDs tend to
present in clinically recognizable patterns of signs and
symptoms, which can be grouped in eight different clinical
presentations determined by the underlying pathogenesis
(Table 1)[ 5]. Of these, recurrent ENT and airway
infections is by far the most common. It is essential to
be familiar with these clinical presentations to be able to
recognize potential cases of PIDs; knowledge of the
pathogenesis is helpful, but not strictly necessary. In this
respect, an important clue for the potential presence of
PID is the family history: although most children present-
ing with recurrent infections do not have PID, this
becomes much more likely when it runs in the family or
when parents are consanguineous. In those cases, further
investigations should not be postponed. In this section, we
will discuss the categories of PID in relation to the eight
different clinical presentations.
Combined B- and T-cell immunodeficiencies
(predominantly T-cell)
The fate of a child with severe PID is determined by rapid
diagnosis and treatment. This is most urgent for children
with SCID [13], who generally present with failure to thrive
from early infancy in combination with intractable diarrhea.
In addition, unusual (opportunistic) infections or unusually
severe course of infections are part of the clinical spectrum.
In children who present with a severe interstitial pneumo-
Primary immunodeficiencies are more common than generally acknowledged
Knowledge of the eight most common clinical presentations is essential to 
recognise potential PID in time
170 Eur J Pediatr (2011) 170:169–177nia, Pneumocystis jiroveci is the most likely opportunistic
pathogen. The hallmark of SCID is T-cell lymphopenia in
combination with hypo- or agammaglobulinemia. T-cell
lymphopenia is reflected in low lymphocyte counts in the
leukocyte differential. Determination of the immunoglobu-
lins in serum shows decreased levels of IgG, IgA, and IgM.
Pitfalls are the relative lymphocytosis of young infants and
the presence of maternal immunoglobulins in the first
months of life. It is therefore essential to use age-matched
reference values for interpretation of laboratory results [3].
Also, the presence of maternal T-cells in the patient’s
peripheral blood can obscure the T-cell lymphopenia.
Further analysis consists of lymphocyte subpopulation
analysis and subsequent genetic analysis of candidate
genes. In any child with unusual (opportunistic) infections,
or unusually severe course of infections, and who does not
have abnormalities in this initial work-up, further diagnostic
steps should be undertaken considering other PIDs men-
tioned in Table 3. Also, HIV infection has to be excluded at
this stage.
Antibody deficiencies
Congenital agammaglobulinemias generally present with
recurrent ENT and airway infections, but may also present
Predominantely antibody
disorders
Predominantely T-cell
disorders
Phagocyte disorders
Other well defined PIDs
Complement deficiencies
Auto-immune and immune
dysregulation syndromes
Auto-inflammatory syndromes
Unclassified PIDs
Fig. 1 Distribution of PID in Europe according to the ESID patient
registry 2010 (http://www.esid.org/statistics.php?sub=2), n=10,747.
PIDs primary immunodeficiencies, ESID European Society for
Immunodeficiencies
Disease category Diagnoses
a
Combined B- and T-cell immunodefi-
ciencies (predominantly T-cell)
(Severe) combined immunodeficiency, (S)CID; many
different genetic defects
CD40L deficiency
Predominantly antibody deficiencies X-linked or AR agammaglobulinemia
Common variable immunodeficiency disorders (CVIDs)
Specific antibody deficiencies
IgG-subclass deficiency
Selective IgA deficiency
Other well-defined immunodeficiency
syndromes
Wiskott Aldrich syndrome
Ataxia telangiectasia and other DNA repair disorders
Hyper-IgE syndromes
Disease of immune dysregulation Immunodeficiencies with hypopigmentation
Familial hemophagocytic lymphohistiocytosis syndromes (HLH)
X-linked lymphoproliferative syndrome
Autoimmune lymphoproliferative syndrome (ALPS)
Congenital defects of phagocyte
number, function, or both
Severe congenital neutropenia
Cyclic neutropenia
X-linked or AR chronic granulomatous disease (CGD)
Defects in innate immunity Anhidrotic ectodermal dysplasia with immunodeficiency
IL-1 receptor-associated kinase 4 deficiency (IRAK-4
deficiency)
Chronic mucocutaneous candidiasis
Autoinflammatory disorders Familial Mediterranean fever
TNF receptor-associated periodic fever (TRAPS)
Hyper-IgD syndrome
Cryopyrin-associated periodic syndromes
Complement deficiencies Broad spectrum of deficiencies of classical and alternative pathway
complement factors
Hereditary angioedema (C1 esterase inhibitor deficiency)
Table 1 The eight pathogenetic
categories of PID according
to the IUIS
AR autosomal recessive, IUIS
International Union of Immuno-
logical Societies Expert
Committee on Primary
Immunodeficiencies
aThere are >150 primary immuno-
deficiencies; for the complete list of
diagnoses: PID 2009 update, J
Allergy Clin Immunol 2009
Eur J Pediatr (2011) 170:169–177 171with severe bacterial infections in other organ systems [18].
The differential diagnosis is extensive (Table 3). However,
they represent emergencies which are relatively easy to
detect by the determination of immunoglobulin levels.
These basic laboratory tests should not be postponed until
other possibilities have been ruled out. Agammaglobulin-
emia usually presents after the age of 3 months to 2 years
because of an increased susceptibility to bacterial infections
once the infant’s protection by maternal antibodies is
weaning. All three immunoglobulin isotypes are severely
decreased. Analysis of lymphocyte subpopulations will
show the near absence of B-lymphocytes. Determination
of the exact nature of the defect is possible by analysis of
genes that affect early B-cell development. A defect in
Bruton’s tyrosine kinase, causing X-linked agammaglobu-
linemia, is present in 85% of agammaglobulinemic patients.
Infants with a (moderate) decrease of IgG and IgA, but
with normal B-lymphocyte numbers, most likely suffer
from transient hypogammaglobulinemia, which is a self-
limiting condition with a mild clinical course. If the
hypogammaglobulinemia is profound in the presence of
normal or elevated IgM levels, a CD40L deficiency
(Table 1) is part of the differential diagnosis.
Less urgent, but still important in the light of preventing
future damage and decreased quality of life and life span, is
the recognition of the more subtle or late-onset forms of
antibody deficiency like specific antibody deficiencies and
CVID. The latter is defined by a decrease of at least two of
the three immunoglobulin isotypes and a decreased re-
sponse to immunization (ESID–PAGID criteria) in a child
older than 2 years of age. These patients generally present
with recurrent ENT and airway infections [4]. However,
most young children with this clinical presentation do not
have PID. Especially in children below 2 years of age, a
high frequency of upper respiratory tract infections in an
otherwise healthy child is very common. An increased
exposure to infections in day care centers, increased
susceptibility to infections secondary to cigarette smoke
exposition, adenoidal hypertrophy, and bronchial hyperre-
activity and/or atopy all contribute to a high frequency of
respiratory complaints. Simple measures and a wait-and-see
approach are fully justified in most cases. However, when
more than one pneumonia occurs, further investigations
into immunological as well as non-immunological causes
are mandatory (Table 3). Also, the frequency of respiratory
infections should decrease when the child grows older.
Medical history
Recurrent (proven) bacterial infections
Two ore more severe infections (pneumonia, sepsis, meningitis, osteomyelitis)
Atypical presentation of infection
Unusually severe course of infection or impaired response to treatment
Infections caused by an unexpected or opportunistic pathogen
Recurrent infections with the same type of pathogen
Abscesses of internal organs or recurrent subcutaneous abscesses
Failure to thrive with prolonged or recurrent diarrhea
Generalized long-lasting warts or mollusca contagiosa
Extensive prolonged candidiasis (oral/skin)
Delayed (>4 weeks) separation of the umbilical cord
Delayed shedding of primary teeth
Family history of immunodeficiency, unexplained infant deaths, or consanguinity of the parents
Difficult-to-treat obstructive lung disease, unexplained bronchiectasis
Atypical autoimmune disease and/or lymphoproliferation
Physical examination
Dysmorphic features, especially facial abnormalities and microcephaly
Partial albinism, abnormal hair, severe eczema, dermatitis
Telangiectasia, ataxia
Gingivitis, oral ulcers/aphthae
Abnormal wound healing
Absence of immunological tissue (lymph nodes, tonsils)
Lymphadenopathy
Organomegaly
Digital clubbing
Vasculitis
Table 2 Symptoms and signs
that can point towards the
presence of PID
Clin Exp Immunol 2006 and the
Jeffrey Modell Foundation
warning signs for PID
172 Eur J Pediatr (2011) 170:169–177When this is not the case, PID becomes more likely, and
further investigations such as repeated serum IgG, IgA,
IgM, and IgG subclasses, specific antibody responses to
vaccination, and a lymphocyte subpopulation screen may
be warranted using age-matched reference values for the
interpretation of the results [3].
Well-defined immunodeficiency syndromes
The occurrence of signs and symptoms that point towards
PID in children with syndromic features is suggestive of the
presence of a well-defined immunodeficiency syndrome.
Recognition of these syndromes requires detailed immuno-
logical and clinical genetic knowledge and warrants further
evaluation for immunodeficiency and examination by a
specialist in clinical genetics. The immunological work-up
depends on the expected syndrome. In case of DNA repair
disorders, analysis should include the determination of
immunoglobulin levels, whereas patients with hyper-IgE
syndromes may suffer from a disorder of granulocyte
function.
Diseases of immune dysregulation
PID syndromes with immune dysregulation form a separate
category of patients in which the increased susceptibility to
infections is not the main problem. A life-threatening
immune dysregulation syndrome is hemophagocytic lym-
phohistiocytosis (HLH). HLH is characterized by an
exaggerated but ineffective immune response which leads
to severe hyperinflammation. Many cases are triggered by
an infection, but the basis is often an inherited defect in
immune effector cells [11,12]. The presentation of familial
HLH is clinically indistinguishable from the HLH associ-
ated with lymphoproliferative syndromes, which are mostly
X-linked and induced by an EBV infection. The major
diagnostic pitfall in HLH is to misdiagnose children as
having sepsis because fever and severe inflammation are
almost invariably present. In any critically ill febrile child
with negative blood cultures and persistent fever despite
antibiotic treatment, HLH should be considered as a
potential diagnosis. Apart from fever, the criteria used to
diagnose HLH include hepatosplenomegaly, bi-cytopenia,
elevated serum ferritin and triglyceride levels, and low
fibrinogen. Furthermore, bone marrow examination can
reveal the presence of hemophagocytosis. Also, an
elevated plasma soluble IL2 receptor level and decreased
NK-cell activity are part of the diagnostic criteria for HLH.
These tests are available in specialized laboratories. When
five of the eight aforementioned diagnostic criteria are
present, the diagnosis of HLH can be made [9]. Treatment
with high dose dexamethasone, etoposide, and ciclosporin
can be life-saving while awaiting hematopoietic stem cell
transplantation (HSCT) as a definitive treatment. Several
genetic defects underlying familial HLH and lymphoprolifer-
ative syndromes are currently known [10], so genetic studies
are necessary once the clinical diagnosis has been made.
Apart from HLH, an immune dysregulation syndrome
should be considered in children with atypical presenta-
tions of autoimmunity, such as autoimmune poly-
endocrinopathy and/or enteropathy. In children with
autoimmune cytopenia, generalized lymphadenopathy
(most prominent in the head and neck region), and
splenomegaly, an autoimmune lymphoproliferative syn-
drome (ALPS) has to be considered. The determination of
lymphocyte subpopulations frequently shows an increased
proportion of CD4−CD8− double negative T-cells in these
patients. ALPS is a disorder of the mediators of lympho-
cyte apoptosis, of which Fas (CD95) is most often
affected. Diagnosis can be made by functional analysis
of Fas expression and sequence analysis of the
corresponding gene.
Disorders of granulocyte number or function
Recurrent non-superficial pyogenic infections and recurrent
ENT and airway infections can both point towards a
granulocyte disorder. A third, much rarer presentation
consists of unusual (opportunistic) infections with Asper-
gillus species or other fungi. Congenital neutropenia is a
granulocyte disorder which can be easily identified by a full
blood count with differential. In case of neutropenia in the
first years of life, the differential diagnosis of benign
For immunoglobulin levels and lymphocyte subpopulations always use 
age-specific normal values
The major diagnostic pitfall in HLH is to misdiagnose children as having sepsis 
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174 Eur J Pediatr (2011) 170:169–177neutropenia of infancy or autoimmune neutropenia has to
be explored because this disease is more common than
congenital neutropenia [6]. The presence of auto-antibodies
against granulocytes supports this diagnosis. The detection
of intermittent episodes of neutropenia suggests cyclic
neutropenia. In that case, the determination of the leukocyte
differential count has to be performed repeatedly to reveal
the cyclic pattern (Table 3). Disorders of granulocyte
function should be considered when granulocyte counts
are not reduced; the diagnosis can be explored by
performing granulocyte function tests.
Defects of innate immunity
Over the last couple of years, several defects in innate
immunity have been discovered representing a new group
of PIDs characterized by defects in pathogen recognition
receptor signaling (e.g., IRAK-4 deficiency), predisposing
these patients to pyogenic infections [14]a n drecurrent
ENT and airway infections, mainly in the first decade of
life. If there is no evidence for other PIDs such as
antibody deficiency or granulocyte disorders in patients
with persistent or recurrent severe bacterial infections, it is
advisable to explore the possibility of a defect in innate
immunity.
Autoinflammatory disorders
Children with autoinflammatory disorders are frequently
considered to have recurrent infections because of their
febrile episodes, which are characteristically periodic.
But these patients do not have an increased susceptibil-
ity to infections. Familial Mediterranean Fever (FMF) is
by far the most common and is mainly found in
populations from the eastern Mediterranean area. Apart
from periodic fever, the clinical manifestations consist
of abdominal pain secondary to serositis, often misdiag-
nosed as appendicitis, and acute (mono)arthritis. There
is a marked inflammatory response, reflected in a high
C-reactive protein level and erythrocyte sedimentation
rate. FMF is caused by autosomal recessive mutations in
the MEFV g e n e ,c o d i n gf o rp y r i n ,w h i c hi sa ne s s e n t i a l
modulator of the inflammatory response. An important
long-term complication is renal failure, which can be
prevented by prophylactic colchicin treatment. Much rarer
autoinflammatory syndromes are tumor necrosis factor
receptor-associated periodic syndromes (TRAPS), meval-
onate kinase deficiency or hyper IgD syndrome, and the
cryopyrin-associated periodic syndromes. For diagnosis
and treatment of these disorders, we refer to a recent
review [19].
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Recurrent meningococcal infections (meningitis/sepsis) are
very suggestive of deficiencies of the terminal components of
the complement system (C5–C9) and warrant screening ofthe
classical (CH50) and alternative (AP50) complement path-
ways. If these screening tests are abnormal, analysis of the
individual components of the complement system will yield
the exact diagnosis. A deficiency of C3, the major opsonin, is
associated with recurrent pyogenic infections with encapsu-
lated bacteria. Although complement deficiency increases
the host’s susceptibility to respiratory tract infections because
of impaired opsonophagocytosis of encapsulated bacteria, a
complement deficiency is seldom diagnosed in children with
recurrent ENTand airway infections. Themainreasonforthis
is the rarity of complement deficiencies compared to antibody
deficiencies and granulocyte disorders [7]. Some complement
deficiencies do not result in increased susceptibility to
infections but to other diseases; a deficiency of complement
regulatory proteins factor H, I, and MCP account for
approximately 50% of the cases of atypical hemolytic uremic
syndrome, whereas a deficiency of the early components of
the classical pathway (C1, C2, C4) predispose children to
systemic lupus erythematodes. A deficiency of mannose
binding lectin, a component of the lectin pathway of the
complement cascade, is not considered to be a PID because it
often occurs in healthy individuals [9].
Treatment and prognosis
Because infections are the main problem in PIDs, prevent-
ing them is the hallmark of treatment. How this is achieved
depends on the underlying condition. Vigorous antibiotic
treatment of bacterial infections is important. Children with
milder antibody deficiencies like specific antibody deficiency
may do very wellon antibiotic prophylaxis, but itis important
to remain vigilant for lung and ear damage which may
develop very slowly but irreversibly nonetheless. For more
severe forms of antibody deficiency immunoglobulin substi-
tution, administered either subcutaneously or intravenously, is
the treatment of choice. Close surveillance is necessary in
children who use it. Immunoglobulin substitution reduces the
frequency of pneumonia in antibody-deficient patients [2],
but cannot prevent pulmonary complications in all patients.
Severe forms of PID can generally only be treated by HSCT,
which is performed in selected highly specialized centers only.
Gene therapy becomes increasingly available for severe forms
of PIDs [1], like some forms of SCID. For patients with
congenital neutropenia, regular subcutaneous treatment with
recombinant granulocyte-colony stimulating factor (G-CSF) is
able to restore granulocyte numbers to near normal levels in
most patients [17].
The fate of children with PID rests on three pillars: (1)
timely recognition, (2) adequate therapy and surveillance, and
(3) the nature of the underlying disease. The last item cannot
be changed. The first is the task of the pediatrician who
encounters the child for the first time, and the second a
combined task of the general pediatrician and pediatric
immunologist who do the follow-up. With appropriate care,
the prognosis of SCID has changed from invariably fatal into
>90% survival when HSCT with an HLA-matched donor is
performed in time [8]. Immunoglobulin substitution has
changed the clinical course of children with agammaglobu-
linemia dramatically, as has recombinant G-CSF administra-
tion for children with congenital neutropenia. The challenge
for the future is to achieve an optimal quality of life and
increased life span for all children with PID. In this respect,
the general pediatrician plays a crucial role: being vigilant
and inquisitive, he/she will be able to recognize these
patients in time, which is a critical step towards achieving
this goal.
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